EphA2 receptor represents a new marker and therapeutic target in pediatric malignancies

被引：0
|
作者：
Couture, D
Wykosky, J
Gibo, DM
Debinski, W
机构：
来源：
NEUROSURGERY | 2005年 / 57卷 / 02期
关键词：
D O I：
10.1093/neurosurgery/57.2.418c
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
866
引用
收藏
页码：418 / 419
页数：2
相关论文
共 50 条
  • [31] The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting
    Wykosky, Jill
    Debinski, Waldemar
    MOLECULAR CANCER RESEARCH, 2008, 6 (12) : 1795 - 1806
  • [32] Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist
    Dobrzanski, P
    Hunter, K
    Jones-Bolin, S
    Chang, H
    Robinson, C
    Pritchard, S
    Zhao, H
    Ruggeri, B
    CANCER RESEARCH, 2004, 64 (03) : 910 - 919
  • [33] EphA2 is a functional receptor for the growth factor progranulin
    Neill, Thomas
    Buraschi, Simone
    Goyal, Atul
    Sharpe, Catherine
    Natkanski, Elizabeth
    Schaefer, Liliana
    Morrione, Andrea
    Iozzo, Renato V.
    JOURNAL OF CELL BIOLOGY, 2016, 215 (05): : 687 - 703
  • [34] RETRACTED ARTICLE: EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma
    Mark S Duxbury
    Hiromichi Ito
    Michael J Zinner
    Stanley W Ashley
    Edward E Whang
    Oncogene, 2004, 23 : 1448 - 1456
  • [35] Evaluation of EphA2 as a therapeutic target for redirected T-cell killing by DART® bispecific molecules
    Fieger, Claudia B.
    Shah, Kalpana
    Chichili, Gurunadh
    Li, Jonathan
    Son, Thomas
    Hooley, Jeffrey
    Chen, Francine
    Gorlatov, Sergey
    Burke, Steve
    Ciccarone, Valentina
    Alderson, Ralph
    Loo, Deryk
    Johnson, Syd
    Bonvini, Ezio
    Moore, Paul
    CANCER RESEARCH, 2016, 76
  • [36] Retraction Note: EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma
    Mark S. Duxbury
    Hiromichi Ito
    Michael J. Zinner
    Stanley W. Ashley
    Edward E. Whang
    Oncogene, 2023, 42 : 938 - 938
  • [37] Unveiling the therapeutic promise of EphA2 in glioblastoma: a comprehensive review
    Qiu, Caohang
    Sun, Ning
    Zeng, Shan
    Chen, Ligang
    Gong, Feilong
    Tian, Junjie
    Xiong, Yu
    Peng, Lilei
    He, Haiping
    Ming, Yang
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [38] EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
    Charmsaz, Sara
    Beckett, Kirrilee
    Smith, Fiona M.
    Bruedigam, Claudia
    Moore, Andrew S.
    Al-Ejeh, Fares
    Lane, Steven W.
    Boyd, Andrew W.
    PLOS ONE, 2015, 10 (06):
  • [39] Conformational Clamping by a Membrane Ligand Activates the EphA2 Receptor
    Westerfield, Justin M.
    Sahoo, Amita R.
    Alves, Daiane S.
    Grau, Brayan
    Cameron, Alayna
    Maxwell, Mikayla
    Schuster, Jennifer A.
    Souza, Paulo C. T.
    Mingarro, Ismael
    Buck, Matthias
    Barrera, Francisco N.
    JOURNAL OF MOLECULAR BIOLOGY, 2021, 433 (18)
  • [40] Cholesterol inhibits assembly and oncogenic activation of the EphA2 receptor
    Schuck, Ryan J.
    Ward, Alyssa E.
    Sahoo, Amita R.
    Rybak, Jennifer A.
    Pyron, Robert J.
    Trybala, Thomas N.
    Simmons, Timothy B.
    Baccile, Joshua A.
    Sgouralis, Ioannis
    Buck, Matthias
    Lamichhane, Rajan
    Barrera, Francisco N.
    COMMUNICATIONS BIOLOGY, 2025, 8 (01)
12345